C138 - Hot Topics in Headaches and Related Disorders I: Unusual Headaches, Childhood Headaches, and Concussion Management
| Event Time: | Tuesday May 7, 2019 1:00 pm to 3:00 pm |
| Topic(s): | Headache, Foundations in Clinical Neurology for APPs |
| Director(s): | Amy Gelfand MD |
| Description: | This program will address a range of issues relevant to clinical practice that are developing or emerged in recent years. Faculty will cover important updates in the understanding of and management of unusual primary headache disorders, headache in children and adolescents (with a particular focus on migraine), and concussion. The newest therapeutic advances will be covered to prepare physicians for what is to come in terms of novel treatments. This program complements Hot Topics in Headaches and Related Disorders II: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances, but covers independent topics. |
| Completion Message: | Participants should be able to explain more completely to patients (adult and pediatric) the pathophysiology of cluster headache, migraine, and post-traumatic headache, as well as new treatments for the same. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge |
| Start/End Time | Title | Faculty |
|---|---|---|
| 1:00 PM - 1:30 PM | Unusual Headache Disorders and Emerging Therapies | Peter Goadsby MD, PhD |
| 1:30 PM - 2:00 PM | Treating Headache in Children and Adolescents | Amy Gelfand MD |
| 2:00 PM - 2:30 PM | Rules of the Game for Optimal Concussion Management | Christopher Giza MD, FAAN |
| 2:30 PM - 3:00 PM | Questions and Answers | Faculty |
| Speaker | Disclosure |
|---|---|
| Amy Gelfand, MD | Dr. Gelfand has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly, Theranica, Advanced Clinical, Biohaven and Impel Neuropharma and UpToDate. Dr. Gelfand has received personal compensation in an editorial capacity for JAMA Neurology. Dr. Gelfand has received research support from Amgen and Duke Clinical Research Institute. |
| Christopher Giza, MD, FAAN | Dr. Giza has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Highmark Interactive. Dr. Giza has received research support from Avanir, Neural Analytics. |
| Peter Goadsby, MD, PhD | Dr. Goadsby has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Reports grants and personal fees from Amgen and Eli Lilly and Company, and personal fees from Alder Biopharmaceuticals, Allergan, Autonomic Technologies Inc., Biohaven Pharmaceuticals Inc., Dr Reddy's Laboratories, Electrocore LLC, eNeura, Impel NeuroPharma, MundiPharma, Novartis, Teva Pharmaceuticals, Trigemina Inc., medicolegal expert advice, Massachusetts Medical Society, UpToDate, Oxford University Press, and Wolters Kluwer; he holds a patent for magnetic stimulation for headache assigned to eNeura without fee.. Dr. Goadsby has received personal compensation in an editorial capacity for Journal Watch- Massachusetts Medical Society. Dr. Goadsby has received research support from Amgen and Eli-Lilly and Company. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
| 11:45 AM-12:45 PM |
|
Friday Grand Finale: Neuroimaging
|
| 1:00 PM-3:00 PM |
|
S59 -
Migraine: Impact, Treatment Patterns and Resource Utilization
|